SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576885-23-000035
Filing Date
2023-06-07
Accepted
2023-06-07 17:43:47
Documents
4
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686174215.html 4  
1 FORM 4 wk-form4_1686174215.xml 4 3933
2 EX-24.1 acumen-section16limitedp.htm EX-24.1 3963
3 acumen-section16limitedp001.jpg GRAPHIC 195024
4 acumen-section16limitedp002.jpg GRAPHIC 36402
  Complete submission text file 0001576885-23-000035.txt   328158
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BLVD. #900 SOUTH SAN FRANCISCO CA 94080
Business Address
Porter Derrell (Reporting) CIK: 0001706400 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 231000080